论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Gong YP, Li GP, Lei JY, You JY, Jiang K, Li ZH, Gong RX, Zhu JQ
Received 14 October 2017
Accepted for publication 18 February 2018
Published 27 April 2018 Volume 2018:10 Pages 899—906
DOI https://doi.org/10.2147/CMAR.S154135
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Dr Antonella D'Anneo
Background: The optimal treatment strategy for papillary thyroid microcarcinoma
(PTMC) has remained controversial. The purpose of this study was to provide a
new reference value for PTMC to aid the selection of optimal management for
minute lesions.
Patients and
methods: A pool of 1,176 consecutive patients
who met the inclusion criteria were ultimately enrolled in this study. The
correlation of papillary thyroid carcinoma (PTC) tumor size and lymph node
metastasis was analyzed. Receiver operating characteristic curve studies were
conducted to identify the reference value by determining the optimal cut-off
point of size related to lymph node metastasis. To validate our results, all
selected patients were divided into two groups according to the cut-off point
and some of the prognostic factors were compared.
Results: A moderate significant correlation was found between the tumor
size and the average number of lymph node metastases (r =0.502, P <0.01) and the percentage of
lymph node metastasis (r =0.625, P <0.01). The optimal cut-off
reference value was 8.5 mm according to the receiver operating characteristic
curves. Significant differences were observed for PTC prognostic factors, for
example, extrathyroidal extension, multifocality, pathologic (p) N+ stage,
occult metastasis in clinical (c) N− stage, radioactive iodine ablation, and
recurrence between the two groups.
Conclusion: Due to more aggressive behavior and poorer prognosis in larger tumor
size (>8.5 mm), a tumor size ≤8.5 mm in diameter may be favorable to
discriminate PTMC from PTC and aid the selection of optimal management.
Keywords: thyroid neoplasms, carcinoma, papillary, lymph nodes
